## A Controlled Trial to Improve Care for
# Seriously III Hospitalized Patients

###### The Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments (SUPPORT)

The SUPPORT Principal Investigators

###### Objectives.\p=m-\Toimprove [end-of-life][ decision] making [and][ reduce][ the] frequency PUBLIC HEALTH and clinical medi¬
of a mechanically supported, painful, and prolonged process of dying. cine during this century have given

Design.\p=m-\A2-year prospective [observational] study (phase I) [with][ 4301] patients Americans the opportunity to live longer
followed by a 2-year controlled clinical trial (phase II) with 4804 patients and their and more productive lives, despite pro¬

###### gressive [illness.][ For][ some] patients, [how¬]
 physicians [randomized] by specialty group [to][ the][ intervention] group (n=2652) [or]
control group (n=2152). ever, [this] progress [has][ resulted][ in] pro¬

###### longed dying, accompanied by [substan¬]
 Setting.\p=m-\Fiveteaching hospitals [in][ the][ United][ States.] tial emotional and financial expense.1
Patients.\p=m-\Atotal of 9105 adults hospitalized with one or more of nine Many [Americans] today [fear] they [will]
###### life-threatening diagnoses; [an][ overall][ 6-month] mortality [rate] of [47%.] lose control over their lives if they be¬
 Intervention.\p=m-\Physicians[in][ the][ intervention] group [received][ estimates][ of][ the] come critically ill, and their dying will
likelihood [of] 6-month survival for every day up to 6 months, outcomes of cardiopul- be prolonged and impersonal.2 This has
monary [resuscitation] (CPR), [and][ functional] disability [at][ 2][ months.][ A] specially [trained] led to an increasingly visible right-to-
nurse had multiple contacts with the patient, family, physician, and hospital staff to die movement. Two years after voters
elicit preferences, improve understanding of outcomes, encourage attention to pain in California and Washington State nar¬
###### control, [and][ facilitate][ advance][ care] planning [and] patient-physician [communication.] rowly [defeated][ referenda][ on] physician-

assisted euthanasia, Oregon voters ap¬

Results.\p=m-\Thephase [I] observation documented shortcomings in communica-

###### proved physician prescription [of][ lethal]
 tion, frequency [of] aggressive treatment, and the [characteristics] of hospital [death:] medications for persons with a terminal only [47%][ of] physicians [knew][ when][ their] patients preferred [to][ avoid] CPR; [46%][ of] disease.3·4 Physicians and ethicists have
do-not-resuscitate (DNR) orders were written within 2 days of death; 38% of patients debated when to use cardiac resuscita¬
###### who died spent at least 10 days in an intensive care unit (ICU); and for 50% of con- tion and other aggressive treatments
scious patients who died in the hospital, family members reported moderate to se- for patients with advanced illnesses.6,6
vere pain at least half the time. During the phase II intervention, patients experienced Many worry [about][ the][ economic][ and][ hu¬]
no improvement in patient-physician communication (eg, 37% of control patients man cost of providing life-sustaining
and 40% of intervention patients discussed CPR preferences) or in the five targeted treatment near the end of life.79
###### outcomes, ie, incidence or timing of [written][ DNR][ orders] (adjusted ratio, 1.02; 95%
confidence interval [Cl], 0.90 to 1.15), physicians' knowledge of their patients'pref- For editorial comment see 1634.
erences not to be resuscitated (adjusted ratio, 1.22; 95% Cl, 0.99 to 1.49), number
of days spent in an ICU, receiving mechanical ventilation, or comatose before death In response, professional organiza¬

###### (adjusted ratio, 0.97; [95%] Cl, [0.87][ to] 1.07), [or] [level][ of] reported pain (adjusted ratio, tions, [the] judiciary, [consumer] organiza¬ 1.15; [95%] Cl, [1.00][ to] 1.33). [The] intervention also [did][ not][ reduce][ use] [of] hospital [re-] tions, [and][ a] president's [commission][ have]
sources (adjusted ratio, 1.05; 95% Cl, 0.99 to 1.12). all advocated more emphasis on realis¬

Conclusions.\p=m-\Thephase I observation of SUPPORT confirmed substantial tically forecasting outcomes of life-
###### shortcomings [in][ care][ for] seriously [ill] hospitalized [adults.][ The] phase [II][ intervention] sustaining [treatment][ and][ on] improved
failed to improve care or patient outcomes. Enhancing opportunities for more communication between physician and
###### patient-physician communication, although [advocated][ as][ the] major [method][ for][ im-] patient.21016 [Statutes] requiring [informed]

consent and communication, like the Pa¬

###### proving patient outcomes, may be inadequate [to] change established practices. To tient Self-determination Act,17 have been improve [the] experience [of] seriously [ill] and dying patients, greater [individual][ and] passed. [Advance][ care] planning [and][ ef¬]
societal commitment and more proactive and forceful measures may be needed. fective ongoing communication among

(JAMA. 1995;274:1591-1598) clinicians, patients, [and][ families][ are][ es¬]

sential to achieve these goals. Previous
studies indicate, however, that commu¬

A complete list of the SUPPORT principal investi- the views of the Robert Wood Johnson Foundation or nication is often absent or occurs only
gatorsarticle. [and] collaborators appears [at][ the][ end] of [this] theirReprint Board requests of Trustees.[to][ ICU][ Research][ Unit,][ Box][ 600,] during [a][ crisis.1820] Physicians today [of¬]

The opinions and findings contained [in] this article are University [of] Virginia [Health][ Sciences][ Center,][ Char-] ten perceive death as failure,1 they tend
those of [the] authors and do not necessarily represent lottesville, [VA][ 22908] (William A. Knaus, MD). to be too pessimistic regarding prog-


-----

###### daily newly qualified patients. responses

Phase I of the Study to Understand Phase I enrolled patients from June strategy [that][ mirrors][ clinical] practice.
###### Prognoses [and][ Preferences][ for][ Outcomes] 1989 to June 1991, and phase II enrolled Important [elements][ of][ the] patient/sur¬
and Risks of Treatments (SUPPORT) patients [from] January [1992] through rogate questionnaires [were][ retested][ for]
confirmed barriers to optimal manage¬ January [1994.][ Patients][ were][ recruited] reliability. [Initial][ and] repeat responses
ment and shortfalls in patient-physician from five medical centers: Beth Israel had greater than 80% agreement.
communication.23·24 The phase II inter¬ Hospital, Boston, Mass; [MetroHealth] The most senior available physician
vention sought to address these defi¬ Medical Center, Cleveland, Ohio; Duke acknowledging responsibility [for][ the] pa¬
ciencies by providing physicians with University [Medical] Center, Durham, tient's medical decisions was interviewed
accurate predictive [information][ on] [fu¬] NC; [Marshfield][ Clinic/St] Joseph's [Hos¬] in the first and second weeks after pa¬
ture functional ability,26 survival prob¬ pital, Marshfield, Wis; [and][ the][ Univer¬] tient enrollment (median days, 3 and 11,
###### ability [for][ each] day up [to][ 6] months,26 [and] sity [of][ California][ at][ Los] Angeles [Medi¬] respectively). [In][ both] interviews, [we] patient preferences [for][ end-of-life] care; cal Center. An independent committee asked the physician's understanding of
a [skilled][ nurse] augmented [the][ care] team monitored potential adverse events, in¬ the patient's preferences for CPR. In
to elicit patient preferences, provide cluding [6-month] mortality [for][ interven¬] the second interview, physicians as¬
prognoses, [enhance] understanding, [en¬] tion patients and changes in patient sat¬ signed [to][ the][ intervention][ were] queried
able palliative care, and facilitate ad¬ isfaction with medical care. Mortality about its influence on the patient's care.
vance planning. We hypothesized that follow-up [to][ 6][ months][ was] complete [for] Physician response [rates][ were][ 86%][ for]
increased communication and under¬ all phase I patients. In phase II, 22 pa¬ the first interview and 82% for the sec¬
###### standing [of] prognoses [and] preferences tients (0.5%) were unavailable for follow- ond interview.
would result in earlier treatment deci¬ up [at][ a][ median][ of][ 80] days.

Phase II Intervention

###### sions, [reductions][ in][ time] spent [in][ unde¬]
sirable states before death, and reduced Data Collection Methods Presented with early findings from
resource use. This article describes the Data collection was based on both con¬ phase [I] documenting [substantial][ short¬]
effect of the SUPPORT intervention on current and retrospective medical re¬ comings [in] communication, [decision][ mak¬]
five specific outcomes: physician under¬ cord reviews and on interviews with pa¬ ing, [and] outcomes,23,24 physicians [at][ the]
###### standing [of] patient preferences; [inci¬] tients, patient surrogates [(defined][ as][ the] participating [institutions][ voiced][ inter¬]
dence and time of documentation of do- person [who][ would][ make][ decisions][ if][ the] est in attempting change. Physician [lead¬]
not-resuscitate (DNR) orders; pain; time patient [was][ unable][ to][ do] so), [and] pa¬ ers and study investigators at the sites
###### spent [in][ an][ intensive][ care][ unit] (ICU), tients' physicians. met to discuss how decision making could
comatose, [or] receiving [mechanical][ ven¬] Medical Record-Based Data.—We be improved to more closely reflect both
###### tilation before death; and hospital re¬ collected physiological indicators of probable [outcomes][ and] patient prefer¬
source use (Figure 1). disease severity,29,30 length of stay, a ences and ways to improve patient, fam¬

modified version of the Therapeutic In¬ ily, [and] physician [communication.] Phy¬

METHODS tervention Scoring System,31 and comor- sicians suggested that communication

Phase I was a prospective observa¬ bidities from the medical records on days could improve if there were more reli¬
tional study that described the process 1,3, 7,14, [and][ 25.][ The] permanent [medi¬] able and prompt information generated
of decision making and patient outcomes. cal record was retrospectively reviewed by [the] study [and][ if] study personnel
Phase II was a cluster randomized con¬ for discussions or decisions concerning would make it more efficient to have
trolled clinical trial to test the effect of 18 important issues, such as the use of conversations. In response to these sug¬
the intervention. Enrollment, data col¬ dialysis, [withdrawal][ from][ a] ventilator, gestions, [the] phase [II][ intervention][ aimed]
###### lection, [and] interviewing [were] virtually and DNR orders. Reliability testing on to improve communication and decision
identical during the two phases.21,23"28 10% of the medical records showed at making by providing timely [and][ reliable]

least 90% agreement on abstracted data. prognostic information, by eliciting [and]

Enrollment Interview Data.—Patients and their documenting patient [and] family prefer¬

###### Qualified patients [were][ in][ the][ ad¬] designated surrogates [were][ interviewed] ences and understanding of disease prog¬
vanced stages of one or more of nine in the hospital between days 2 and 7 nosis and treatment, and by providing a
illnesses: acute respiratory failure, mul¬ (median, day [4)][ and] again [between] days skilled nurse to help carry out the needed
###### tiple organ system [failure][ with] sepsis, 6 and 15 (median, day 12) after study discussions, [convene][ the] meetings, [and] multiple organ system [failure][ with][ ma¬] enrollment, [whether][ or][ not][ the] patient bring [to][ bear][ the][ relevant][ information.] lignancy, coma, [chronic][ obstructive] lung remained hospitalized. The surrogate The elements of the intervention and disease, congestive [heart] failure, [cirrho¬] was interviewed 4 to 10 weeks after the their timing are presented in Table 1. sis, [metastatic][ colon] cancer, [and][ non-] patient's [death.] Among [the][ 45%][ of] pa¬ In each case, the nurse was free to
small cell lung cancer. Patients were tients who were able to communicate, shape [her][ role][ so][ as][ to][ achieve][ the][ best]
excluded if they were younger than 18 the response rate for the first interview possible [care][ and][ outcome.][ For] example,
years, [were] discharged [or][ died][ within] was 85%. The surrogate response rate she sometimes engaged in extensive
48 hours of qualifying for the study, were for the first interview was 87%. For the emotional support. Other times, she
admitted with a scheduled discharge second-week interviews, the patient re¬ mainly provided [information][ and] en¬
###### within 72 hours, did not speak English, sponse [rate][ was][ 71%][ and][ the] surrogate sured that all parties heard one another
were admitted to the psychiatric ward, response [rate][ was][ 78%.][ The][ interviews] effectively. [All][ of][ the][ nurses'][ involve¬]
had acquired immunodeficiency syn¬ collected information on patient demo¬ ment required approval of the attend¬
###### drome, [or][ were] pregnant [or][ sustained] graphics, [functional] status, [self-assessed] ing physicians. [In] virtually [all] cases, [the]
an acute burn, head, or other trauma quality [of] life, [communication][ with] phy¬ physician approval [came][ with][ no][ limits.]
###### (unless they [later] developed acute [res¬] sicians, frequency [and] severity [of] pain, Physicians [were] free, however, [to][ limit] piratory [failure][ or] multiple organ sys¬ satisfaction with medical care,32 and the the intervention in any way that they
tem failure).26·28 Nurses trained in the patient's preferences [for] cardiopulmo- felt was best for the patient, and there


-----

###### gression log use,
which was then converted to 1993 dol¬

Phase I (1989 to 1991) lars. This method allows comparisons of
Study [4301][ Patients][ at][ Five] Teaching Hospitals groups [and][ institutions][ across][ time][ with¬]

                 - Describe Outcomes out having to adjust for varying hospital

                                     - Develop Identify Shortcomings Prognostic Models of Care billing practices.

                               - Establish Design Intervention Adjustment Methods Power and Safety Calculations

Power calculations based on phase I
data indicated greater than 90% power
###### (a=.05) to [detect] a 1-day [decrease][ in]

112152 Physician PatientsControl Groups (45%) RandomizedApplyPhasell[Intervention] by (1992 27 Physician[ to][ 4804][to] 1994)[ Patients] Groups 162652 PhysicianIntervention Patients Groups (55%) days5% increase[until][ a][ DNR] in the[ order] proportion[ was] written, of physi¬[a]

cians and patients agreeing on a DNR
###### order, [a][ 20%][ decrease][ in][ undesirable] days, [a][ 10%][ decrease][ in] reported pain,

Adjusted Analyses [of] and a 5% decrease in resource use. Ef¬
Intervention [vs] Control for Five Outcomes fects of the intervention on mortality

              - Incidence and Timing of Written DNR Orders rates were quantified by [the][ estimated]

             - Patient-Physician Agreement on CPR Preferences intervention, [control][ hazard][ ratio][ from]

                         - DaysVentilation in an ICU, Before Comatose, Death or Receiving Mechanical adjusted [Cox][ models.33]

              - Pain

             - Hospital Resource Use Adjustment [Methods]

for Phase II Results

Because patients were assigned to in¬

Figure [1.—Overall][ schematic] presentation [of] phases [I][ and][ II][ of][ the] Study [to][ Understand] Prognoses [and] tervention or control status based on a
Preferences for Outcomes and Risks of Treatment (SUPPORT) project, 1989 [to] 1994. [DNR] indicates [do] limited number of specialty groups, the
not resuscitate; CPR, cardlopulmonary resuscitation; and ICU, [Intensive] care [unit.] resulting [cohorts] might [be][ unbalanced]

in patient baseline risk factors. Further¬

was no requirement for them to share or gression [model][ to] prepare Kaplan-Meier more, practice patterns among [the] phy¬
discuss the information with the patient predicted [median][ time][ until][ the][ first][ DNR] sician specialty groups in phase I dif¬
or family or to allow the nurse's involve¬ order was written. If a DNR order was fered substantially. We controlled for
ment to continue. The nurse was [iden¬] not written, DNR order timing was these expected preintervention differ¬
###### tified on her badge and in the consent censored at the day of death or hospital ences using baseline multivariable risk
process [as] part [of][ a][ research] effort, [but] discharge. (2) [Patient][ and] physician agree¬ scores that were derived by generating
she had the role and appearance of a ment on preferences to withhold [resus¬] models to predict phase I outcomes, each
###### typical [clinical] specialist. citation was based on the first interview of which incorporated interactions be¬
 Randomization.—To limit contami¬ of the patient (or surrogate if the patient tween physician specialty [and] hospitals. nation, patients [were] assigned [to][ inter¬] was unable to be interviewed) and the Observed imbalances in phase II base¬
vention or control (usual care) status responsible physician. Agreement [was][ de¬] line patient characteristics were also ad¬
based on the specialty oftheir attending fined as a response to forgo resuscitation justed using [a] propensity [score][ that][ cor¬]
###### physician. Physician specialties [were][ di¬] from both patient and physician, analyzed rected for selection bias associated with
vided into five groups: internal medi¬ with binary logistic regression, and ap¬ being assigned [to][ intervention][ status.34]
###### cine, pulmonology/medical ICU, [oncol¬] plied [to][ all][ interviewed] patients [or][ sur¬] Further details on the construction of
ogy, surgery, [and] cardiology. [We][ used][ a] rogates [who][ had] matching physician both of these risk scores are available on
cluster randomization scheme to assign interviews. (3) Days spent in an ICU, request. Imputation [methods][ for][ miss¬]
the intervention randomly to 27 physi¬ receiving [mechanical] ventilation, [or][ co¬] ing [data][ have][ been] published.25 Finally,
cian group-site combinations, restricted matose before death were analyzed using we simulated the phase II randomiza¬
###### by [the][ conditions][ that][ 50%][ to][ 60%][ of] ordinary least-squares regression [(after] tion scheme on the phase I data to evalu¬ patients [would][ be] assigned [intervention] taking [the] log [of][ 0.5] plus [the][ number][ of] ate secular trends. To adjust [for][ mul¬] status, [and][ that][ at][ least][ one][ interven¬] days) [and] only [included] phase [II] patients tiple outcomes, [our][ methods] prespeci-
tion and one control physician specialty who died during the index hospitaliza- fied adjusting confidence intervals (CIs)
group [be][ at][ each][ of][ the][ five] study [in¬] tion. (4) Frequency and severity of pain using [the][ method][ of] Hochberg [and][ Ben-]
stitutions. This resulted in 11 physician analyses [were][ based][ on][ all] patients [or] jamini35 [if][ more][ than][ one] [value][ was]
###### specialty groups assigned [to][ control][ and] surrogates [interviewed][ in][ the][ second] less than .05. All statistical analyses were
16 assigned to the intervention (Figure week with a combined measure (moder¬ done with UNIX S-Plus, version 3.2 soft¬
1). Analyses [were][ based][ on][ allocation][ to] ate or severe pain all, most, or [half][ the] ware36 and the Design library.37
intervention (ie, intention to treat), ir¬ time) [and] analyzed using [a] single, [ordinal] RESULTS
###### respective [of][ whether·][ a] given patient logistic regression [model.][ (5)] Hospital [re¬]
received the intervention. Investigators source use was defined as the log of the Phase I Observations
were blinded to the phase II results dur¬ product [of][ the] average Therapeutic [In¬] Phase I enrolled 4301 patients (Fig¬
###### ing [data][ collection.] tervention Scoring System rating and ure 1) with a median age of 65 years and
 Analytic [Methods.—Five] measures length [of] hospital stay [after][ the][ second] other characteristics summarized in
were chosen to evaluate the interven¬ day [of][ the] study. [In] regression analyses Table 2. The mean predicted 6-month
tion: (1) The timing of written DNR or¬ on phase I data, this measure closely es¬ survival probability was 52% with an
ders was analyzed with a log-normal re- timated hospital bills across the five study actual 6-month survival probability of


-----

Feedback of phase I results

Benchmarking [information] All intervention physicians Early phase [I] (Table 2).

describing phase [I][ Incidence]
of patient-physician
communication, pain, Delivery [of][ the][ Intervention]
and timing of DNR order

###### Ninety-five percent [of][intervention] pa¬

PrognosticSurvival time[information] estimates for up Intervention physicians and Study days [2, 4, 8,][ 15,] tients received one or more patient-spe¬

to 6 mo26 medical record and 26 cific components ofthe intervention. The

Prognosis [for][ outcome][ for][ CPR] Intervention physicians and Study day [2] SUPPORT nurse was involved in the

if needed26 medical record care of all but 133 patients, and 75 of

Survivalby physician26 estimates, enhanced Interventionand medical physicians record Study day [4] these were patients who died or were

###### discharged [on][ the] day [of][ enrollment.]

Prognosis,disability, probability[at][ 2][ mo25] [of][ severe] Interventionmedical record physicians [and] Study day [8] The SUPPORT nurse communicated

Interview information with the physician in virtually all cases.

Patient and surrogate report of Intervention physicians and First and second study weeks She talked directly with the patient or

prognosis,CPR, [advance] preferencesdirectives,[about] quality medical record family [in][ most][ cases] (eg, [with][ 84%][ con¬]
of life, information desires, [and] cerning prognosis, [77%][ about] pain, [63%]
pain about likely outcomes or resuscitation,

Interview on knowledge of Intervention physicians Study day [10] and 73% concerning written advance

preferencest directives). [For] patients [in][ the] hospital

NurseExplainingand involvement interview prognostic reports[estimates] Patient,physicians, family,[and] staff,[ medical][intervention][ records] Studyuntil day death[3][ and] or 6continuously mo forfor 7 the or study,more the days median after number qualifying of

Enhancing understanding [of] likely Patient, family, staff, [intervention] Study day [3][ and] continuously SUPPORT nurse contacts with the pa¬

outcomes/preferences physicians, [and][ medical][ records] until death or 6 mo tient, family, [or] physician [was][ four][ and]

Eliciting [and] documenting Patient, family, staff, [intervention] Study day [3][ and] continuously the mean was six. Documentation in the

preferences/advance [directives] physicians, [and][ medical][ records] until death or 6 mo

progress [notes][ of][ discussions][ about] pa¬

Assessingtreatment pain [and] enabling Patient,physicians, family,[and] staff,[ medical][intervention][ records] Studyuntil day[death][3][ and][ or][ 6]continuously[ mo] tients' preferences with regard to re¬

suscitation was increased from 38.5% in

Voicing patient/family preferences Patient, family, staff, [Intervention] Study day [3][ and] continuously

and values physicians, [and][ medical][ record] until death or 6 mo phase [I][ to][ 50.3%] among phase [II][ inter¬]

Convening meetings, negotiating Patient, family, staff, [intervention] Study day [3][ and] continuously vention patients.

agreements physicians, [and][ medical][ records] until death [or][ 6][ mo] The patient's physician received at

Encouraging planning [for][ future] Patient, family, staff, [intervention] Study day [3][ and] continuously least one prognostic report for 94% of

decisions physicians, [and][ medical][ records] until death or 6 mo patients, [and][ the] report [was] put [in][ the]

"SUPPORT indicates Study to [Understand] Prognoses [and][ Preferences] for Outcomes [and] Risks of Treatment; medical record of80%. The patient's phy¬
DNR, [do][ not] resuscitate; CPR, cardiopulmonary resuscitation; [and] ICU, intensive [care][ unit.] sician received at least one printed re¬

tPhysician [interview][ on] day [10][ was][ for][ evaluation,][ not][ part][ of][ the][ intervention.] port [of]patient [or] surrogate [understand¬]

48% (Table 2). Thirty-one percent of We found substantial variation in the ingNo[and] physicianpreferences refused[in][ 78%] to receive[ of][ cases.] the
###### phase [I] patients [with][ interviews] pre¬ five outcomes among physician specialty
 printed reports [or][ to][ have][ them][ shared]

ferred that CPR be withheld, but only groups [and][ across][ the][ five][ institutions.] with other professional staff. The phy¬
47%ported of their[this] preference physicians during accurately[the][ first] re¬ Acrossof days institutions, spent in an ICU the before median death number var¬ thesicians SUPPORT for 43 patients nurse refused to have to contact allow
interview. Nearly half (49%) of the 960 ied from 5 to 9. The proportion ofpatients with the patient and family, and seven
###### phase [I] patients [who][ indicated][ a][ desire] reporting [moderate][ to][ severe] pain [at][ least]
for CPR to be withheld did not have a halfthe time varied by a factor of2.7, from patientswith the SUPPORT[or] surrogates nurse.[refused][ to] speak
DNR order written during that hospi- 12% to 32% across study institutions. The
talization. Nearly one third of these pa¬ predicted [median][ number][ of] days [until][ a]
tients (278 [29%]) died before discharge. DNR order was written for a standard Effect of Intervention on Outcomes

###### Among [all] phase [I] patients [who][ died] patient [varied] by [a][ factor][ of][ 3.5,][ from][ 73] The prevalence or timing of documen¬ during [the][ index] hospitalization [(n=] [1150),] days [for] patients [on a] surgical [service][ to] tation of DNR orders for the 2534 in¬
79% died with a DNR order, but 46% of 22 for oncology. One study institution had tervention patients was the same as for
these orders were written within 2 days a predicted median time until DNR was the 2208 control patients (adjusted ratio
of death. Among all phase I deaths, the written for a standard patient of 28 days, of median time, 1.02; 95% CI, 0.90 to
median number of days spent in an ICU, and another institution had a predicted 1.15) (Table 3). [There][ was][ a][ small][ asso¬]
comatose, [or] receiving [mechanical][ venti¬] median time of 49 days. Agreement on ciation of the intervention with improved
lation was 8, more than one third (38%) DNR varied from 8% for cardiology pa¬ patient-physician [DNR] agreement [for]
###### spent [at][ least][ 10] days [in][ an] ICU,[ and][ 46%] tients to 24% for oncology patients and the 1480 intervention patients who had
received mechanical ventilation within 3 from a low of 8% at one study institution patient [or] surrogate [and] matching phy¬
###### days [of] [death.][ In][ the][ second] week, [22%][ of] to a high of 27% at another. The median sician interviews, compared with 1159 patients reported being [in][ moderate][ to] number of days spent in an ICU before control patients (adjusted ratio, 1.22; 95%
severe pain at least half the time. In in¬ death ranged from 14 in the surgical spe¬ CI, [0.99][ to][ 1.49).][ The][ number][ of] days
terviews conducted after a patient died, cialties to 5 for patients in pulmonary/ spent [in][ an] ICU, [comatose,][ or] receiving
###### surrogates [indicated][ that][ 50%][ of][ all][ con¬] ICU and oncology services. mechanical ventilation before death for
scious phase I patients who died in the the 680 intervention patients who died
###### hospital experienced [moderate][ or][ severe] Phase II Demographics in the hospital was the same as for the pain [at][ least][ half][the][ time] during [their][ last] Phase II enrolled 4804 patients, 2152 530 control patients (adjusted ratio of
3 days of life. assigned [to][ usual][ medical][ care][ and][ 2652] median days, 0.97; 95% CI, 0.87 to 1.07).


-----

Control Intervention

Phase [I] Phase II Group Group AdjustedRatio
(n=4301) (n=4804) (n=2152) (n=2652)

[CI)]

Median age, y 65 64 66 _(95%Median time until DNR order

Sex, [%][ female] 43.0 44.3 43.0 45.4 was written, d 1.02(0.90-1.15)

Race, [%] DNR agreement, % 1.22 (0.99-1.49)

White 79.5 79.0 82.1 Undesirable states, median d 0.97 (0.87-1.07)

Pain, [%] 1.15(1.00-1.33)

Black 15.3 15.4 11.5 19 Resource Use, median

Other 5.3 5.6 6.4 5.0 1993 dollars 1.05(0.99-1.12)

Annual income <$11 000, % 'SUPPORT indicates Study to Understand Prognoses

Education high [school][ or] more, [%] 53.4 59.0 63.2 56 and Preferences for Outcomes and Risks of Treatment;

DNR, [do] not resuscitate; [and] CI, [confidence][ interval.]

Primary [insurance,][ %]

Private 29.2 29.6 32.7 27.1

Medicare 56.0 53.5 patients reported [that] they [would][ like]

Medicaid 11.8 10.8 11.2 10.6 to have such a discussion.

None 5.3 3.6 2.6 4.4

Disease class, % Physician's Perspective

Acute organ system failuret 42.9 49.6 52.8 on Intervention

Chronic diseased 34.4 28.8 25.0 31.8 In the second physician interview, 59%

Nontraumatic coma 5.7 7.3 5.9 8.4 acknowledged receiving [the] prognostic

Cancer§ 16.9 reports [and][ 34%] acknowledged [receiv¬]

Mean ADL Scale scorelffl 1.6 1.5 1.5 1.5 ing [the] preference reports. [Fifteen] per¬

Median APS of APACHE lll||# 33 32 32 cent reported discussing this specific in¬

SUPPORT [6-mo][ mean] survival estimateli 0.52 0.52 0.51 0.52 formation with patients or families.

6-moHospital Mortality, mortality, % [%] 26.7 25.2 24.6 25.6 Nearlysaid they[a] thoughtquarter the[of] SUPPORTrespondents nurses' (22%)

Median hospital charges, $ thousands 21 29 33 27 involvement improved patient care.

*SUPPORT indicates Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment. Safety Monitoring
tlncludes^Includes end-stage[acute] respiratory[cirrhosis][failure][ and][ and]acutemultiple[exacerbations] organ system[ of][ severe] failure congestive[with][ or][ without][heart]sepsis.failure [or][ severe][ chronic] After adjusting for baseline differ¬
obstructive pulmonary disease. ences, [the][ 6-month] mortality [for] phase

(¡Includes [colon][ cancer][ with][ liver][ métastases][ and] stage [III][ or] stage [IV][ non-small][ cell] lung [cancer.] II control patients was the same as for

UADLIIMeasured[indicates][on][ the][ activities][ third] studyof daily day. living [score][ from][ 0][ to] 7, [with][ each] point representing [an] impairment [in][ basic] intervention patients (adjusted relative
function, reflecting patient status [2][ weeks] before [admission.] hazard, 0.95; [95%] CI, [0.87][ to] 1.04). [Both]

The#APS APS[indicates] varies fromacute 0 to physiology 252 with score; a higher[and] scoreAPACHE indicating III, [Acute] greaterPhysiology, physiological Age, instability Chronic [Health] and risk[ Evaluation] of death.III.29 control (68%) and intervention (69%) pa¬

tients or surrogates rated their care as
excellent or very good.

###### Reported pain [increased][ for][ the][ 1677][ in¬] phase I, using [simulations][ of][ the] physi¬

COMMENT

tervention patients and surrogates inter¬ cian specialty groupings used in phase
viewed in the second week, compared with II. None of the five outcomes changed Findings [from] phase [I][ of][ SUPPORT]
the control group (adjusted ratio, 1.15; significantly during [the][ 5] years [of][ the] documented many shortcomings of care.
95% CI, 1.00 to 1.33) (Table 3). There was study. [The][ differences][ between][ those] The SUPPORT "patients were all seri¬
no change in hospital resources used for who would have been assigned to inter¬ ously ill, [and][ their] dying proved [to][ be]
2593 intervention patients not dead or vention and control in phase I persisted predictable, yet [discussions][ and][ decisions]
###### discharged [before][ the][ third] study day [com¬] throughout [the][ SUPPORT] study, [un¬] substantially [in][ advance][ of][ death][ were] pared [with][ 2129][ control] patients (adjusted affected by time or by the intervention. uncommon. Nearly half of all DNR orders
ratio of average resource use, 1.05; 95% were written in the last 2 days of life. The
###### CI, [0.99][ to] 1.12). Communication and Preferences final hospitalization for half of patients

The unadjusted differences between in¬ The intervention did not change the included more than 8 days in generally
tervention and control patients for me¬ unadjusted proportion [of]patients [or][ sur¬] undesirable states: in an ICU, receiving
dian days until the first DNR order was rogates reporting a discussion about mechanical ventilation, or comatose. Fami¬
written were large, especially for patients CPR; [37%][ of] [control] patients [and][ 40%][ of] lies reported that half of the patients who
with colon cancer and non-small cell lung intervention patients reported discuss¬ were able to communicate in their last
cancer for whom the median number of ing [their] preference. [Of] patients [who] few days spent most of the time in mod¬
###### days [until][ a][ written][ DNR][ order][ was][ 80%] did not have such a discussion, 41% of erate or severe pain. Based on a study in
lower in intervention patients. Adjust¬ each group said they would like to dis¬ a defined population at our Wisconsin site,
ment for baseline imbalances reduced cuss CPR. Seventeen percent of control we estimate that patients meeting SUP¬
much of the difference in each category patients [and][ 20%][ of] [intervention] patients PORT criteria account for approximately
###### (Table 4). The [differences][ that] persist in changed [their][ resuscitation] preferences 400 000 admissions per year in the United
the cancer category are of uncertain im¬ to forgo CPR by the second week after States and that another 925000 people
###### portance, being [one] among multiple [com¬] enrollment, [and][ 39%][ of][ control] patients are similarly ill but would not meet SUP¬ parisons [and] being [based][ on][ a][ small][ num¬] and 41% of intervention patients re¬ PORT entry requirements of being hos¬
ber of patients (Table 4). ported having [a][ discussion][ about][ their] pitalized [or][ in][ intensive][ care.38][ Patients]

###### Figure [2][ illustrates][ the][ secular][ trends] prognosis [with][ a] physician. [Of] [those][ who] with SUPPORT illnesses and severity ac¬
of each outcome in the phase II inter¬ did not discuss their prognosis, 44% of count for about 40% of persons dying in
vention and control groups, as well as in control patients and 42% of intervention the defined population.


-----

Acute Acute Acute Acute
Respiratory Exacerbation Advanced Respiratory Exacerbation Advanced
or Multiple of Cirrhosis, Lung [or][ Colon] or Multiple of Cirrhosis, Lung [or][ Colon]
System [Failure] COPD, [or] CHF Coma Cancer System [Failure] COPD, [or][ CHF] Coma Cancer

Median time until DNR order was written, d

Control 46 40 10 58 38

34

DNR agreement, %

Control 13 33 17 25

13 14 21 32

Undesirable states, median d

Control 10 9.5 6.5

10

Pain, [%]

Control 16 20

Intervention 17 18 23 16 12 26

Resource use, [median][ 1993] dollars

Control 20 900 5100

19 500 5600 33 400 8900 22 000 6100

*SUPPORT indicates Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments; COPD, chronic obstructive pulmonary disease; CHF,
congestive [heart][ failure;][ and][ DNR,][ do][ not][ resuscitate.]

###### Building [on][ the] findings [in] phase I, The intervention had no impact on any [claim] that, [if][ the][ health][ care] system
observations of others,1"16'23·24·39"'6 the opin¬ any [of][ these] designated targets [(Tables] is given additional resources for collabo¬
ions of physicians at the five sites, and 3 and 4). Furthermore, even though the rative decision making in the form of
the marked variation in their baseline targeted [outcomes] are objectives of skilled professional time, improvements
###### practices, [the] phase [II][ intervention][ aimed] much ethical and legal writing and of will occur. In phase II of SUPPORT,
to make it easier to achieve better deci¬ some explicit social policy (such as in¬ improved information, [enhanced][ conver¬]
sion making for these seriously ill pa¬ formed consent statutes, the Patient sation, [and][ an] explicit [effort][ to][ encour¬]
tients. The intervention gave physicians Self-determination Act, and guidelines age [use][ of] [outcome][ data][ and] preferences
reliable prognostic information and timely on pain),1017 there were no secular trends in decision making were completely in¬
###### reports [of] patient [and] surrogate percep¬ toward improvement for intervention effectual, despite [the][ fact][ that][ the] study tions, [the][ two][ most] important [factors] or control patients during the 5 years of had enough power to detect small ef¬
cited recently by physicians when con¬ SUPPORT data collection (Figure 2). fects.
###### sidering life-support [decisions][ for][ criti¬] These results raise fundamental ques¬ It is possible that the intervention cally [ill] patients.44 [The][ intervention][ nurse] tions about the intent and design of this would have been more effective ifimple¬
also undertook time-consuming discus¬ trial. Do patients and physicians see the mented in different settings, earlier in
###### sions, arranged meetings, provided [in¬] documented shortcomings as troubling? the course of illness, or with physician formation, supplied forms, [and][ did] any¬ Can enhanced decision making improve leaders rather than nurses as implement- thing [else][ to] encourage [the] patient [and] the experience of seriously ill and dying ers. Perhaps, it would have been effec¬ family [to] engage [in][ an][ informed][ and][ col¬] patients? [Were][ the][ inevitable][ limitations] tive if continued for more time or tested
laborative decision-making process with of this project too great to draw strong at later end points.48 However, the over¬
a well-informed physician (Table 1). conclusions? all results of this study are not encour¬

The intervention was limited by its ap¬ Because there was no movement to¬ aging. [No] pattern emerged [that] implied
###### plication [to][ a][ diverse] group [of] physicians ward what would seem to be better prac¬ that the intervention was successful for
and patients, all of whom had to comply tices, [one][ could][ conclude] [that] physicians, some set of patients or physicians or
###### voluntarily. [The][ intervention][ had][ to][ be] patients, [and][ families][ are] fairly [com¬] that its impact increased over time. The perceived [as] helpful, polite, [and] appro¬ fortable with the current situation. Cer¬ five hospitals had been chosen for their priate. [As][ an][ initial] attempt [to] change tainly, [most] patients [and][ families][ indi¬] diversity [and][ their] willingness [to][ un¬]
outcomes for seriously ill patients, we did cated they were satisfied, no matter dertake a substantial and controversial
not seek authority to be coercive or more what happened to them. Physicians have challenge. [Yet][ none][ showed][ a] tendency
than minimally disruptive. As designed, their established patterns of care, and toward improvement in these outcomes.
###### however, [the][ intervention][ was] vigorously while they were willing to have the SUPPORT did demonstrate, however, applied. [The][ SUPPORT][ nurses][ were][ com¬] SUPPORT nurse present and carrying that issues this complex can be studied mitted, energetic, [and] highly [trained.] They on conversations, physician behavior ap¬ with sufficient scientific rigor to be con¬ engaged [in][ the][ care][ of] virtually [all][ our] peared unchanged. Perhaps physicians fident of the findings. We achieved good patients, [and] nearly everyone [had] printed and patients in this study acknowledged interview response rates among seriously reports [delivered] promptly. problems [with][ the][ care][ of] seriously [ill] ill patients, their families, and physicians,

Because we thought that changes in patients [as][ a] group. However, [when][ in¬] widespread acceptance [of][ the][ interven¬]
the decision-making processes that were volved with their own situation or en¬ tion in diverse hospitals, and high-qual¬
not reflected in improved patient out¬ gaged [in][ the][ care][ of][ their][ individual] pa¬ ity [data.][ Consent][ and] confidentiality [is¬]
comes would not be worth much expense, tients, they [felt] they [were] doing [the] sues were complex but amenable to so¬
we specified five outcomes, each indi¬ best they could, were satisfied they were lution. The analytic issues required ap¬
###### cating [an] important improvement [in] pa¬ doing well, [and][ did][ not][ wish][ to] directly plication [of] relatively [novel] approaches, tient experience, as the main targets of confront problems or face choices.46·47 but they proved effective. The study also
the intervention. The study certainly casts a pall over demonstrated the need for such methods


-----

50- oil25

40 g [c][ 20]

40- I «œ>>is 15

Q

20 10

30 . 5-

###### -1-1—-1-1-1— 5as 0- -1-
1989 1990 1991 1992 1993 1994 1989 1990 1991 1992 1993 1994 1989 1990 1991 1992 1993 1994
Year Year Year

Phase I Phase I 80 Phase I Phase II

    - 80
0. 60-

£ 60
   - Intervention Group

40-

en 40 Control Group
o
20 » 20-

###### -1-1—-1-1-1— -1-
1989 1990 1991 1992 1993 1994 1989 1990 1991 1992 1993 1994
Year Year

Figure [2.—Secular][ trends][ in][ five] patient [outcomes][ In][ the] Study [to][ Understand] Prognoses [and][ Preferences][ for][ Outcomes][ and][ Risks][ of][ Treatment] (SUPPORT) [from]
June 1989 through January 1994. The horizontal axes represent the years of SUPPORT (1989 [to] 1994). The time between phase I and phase II is represented
by [a] space. [The][ intervention][ and][ control] group [lines][ have][ been][ smoothed] nonparametrically. [The] phase [II][ results] represent [the][ actual] impact [of][ the] trial, [and][ the]
phase [I][ results][ are][ the][ baseline][ or][ historical][ differences.][ There][ were][ no] significant [differences][ in][ Intervention] patients [between] phases [I][ and] II, [and][ after] adjustment,
no significant differences were noted between phase II control and intervention patients for the five main outcomes. DNR Indicates do not resuscitate, and ICU,
intensive care unit. (See text for detailed definitions and exact sample sizes.)

when performing evaluations of complex University [of][ California][ at][ Los] Angeles [Medical] abstractors); [Bernice] Arthur, BA, [Carol] Collins, BA,
interventions in seriously ill patients. We Center. Mary Cunnion, BA, [Deborah] Dyer, BA, [Corinne]
would have concluded that the interven¬ National Coordinating Center: William A. Kulak, BS, Mary Michaels, BA, [Maureen] O'Keefe,

Knaus, MD, George Washington University [Medicai] BA, [Marian] Parker, AB, MBA, [Lauren] Tuchin, BA,

tion positively influenced all outcomes Center, Washington, DC, [and][ Joanne] Lynn, MD, Dolly Wax, BA, [and][ Diana] Weld, [A] (interviewers);
had we not had phase I results for base¬ Dartmouth Medical School, Hanover, NH (co- Liz Hiltunen, MS, RN, CS, Geòrgie Marks, MS,
line adjustment and phase II control pa¬ principal investigators); Marilyn Bergner, PhD MEd, RN, Nancy Mazzapica, MSN, RN, [and] Cindy
tients to evaluate secular trends (Table 4 (deceased), [and][ Anne] Damiano, ScD, [Johns] Hopkins Medich, MS, [RN] (SUPPORT [nurse] clinicians); [and]

University, Baltimore, Md; [Rosemarie] Hakim, PhD, Jane Soukup, MS (analyst/data manager).

and Figure 2). George Washington University [Medical] Center, Duke University Medical Center, Durham, NC:

In conclusion, we are left with a trou¬ Donald J. Murphy, MD, Presbyterian-St Lukes William J. Fulkerson, Jr, MD (principal investiga¬
###### bling [situation.][ The] picture [we][ describe] Medical Center, Denver, Colo; Joan Teno, MD, and tor); [Robert][ M.] Califf, MD, Anthony [N.] Galanos,
of the care of seriously ill or dying per¬ Bethlas P. Virnig, Wagner, PhD, PhD, Dartmouth George Washington Medical School; University Doug¬ baier,MD, [Peter][PhD] Kussin,(coinvestigators); MD, [and][ Lawrence][Maria] Winchell,[ H.][ Muhl-][MS]
sons is not attractive. One would Medical Center; and Albert W. Wu, MD, MPH, and (project director); [Lee] Mallatratt, [RN] (chart [ab¬]
###### certainly prefer [to][ envision] that, [when] Yutaka Yasui, PhD, Johns Hopkins University (coin- stractor supervisor); Ella Akin, BA (interviewer
confronted with life-threatening illness, vestigators); [Detra][ K.] Robinson, MA, George [Wash¬] supervisor); Lynne Belcher, RN, [Elizabeth] Buller,
the patient and family would be included ingtonsupervisor); University[Barbara][Medical]Kreling,[ Center] BA, George(chart [abstraction] Washing¬ BSN,RN, Libby RN, Fogelman,[Eileen] Clair, BSN, RN, RN,[Laura][Dianna]Drew, BSN,Frye,
in discussions, realistic estimates of out¬ ton University Medical Center (survey coordinator); BSN, RN, [Beth] Fraulo, BSN, RN, [Debbie] Gessner,
come would be valued, pain would be Jennie Dulac, BSN, RN, Dartmouth Medical School BSN, RN, [Jill] Hamilton, BSN, RN, [Kendra] Kruse,
###### treated, [and] dying [would][ not][ be] pro¬ (intervention implementation coordinator); Rose BSN, RN, [Dawn] Landis, BSN, RN, [Louise] Nobles, longed. [That][ is][ still][ a] worthy [vision.2·49] Baker,Medical MSHyg,Center George (database Washington manager); Universityand Sam BSN,Wheeler, RN, BSN,[Rene] Oliverio,[RN] (chart BSN, abstractors); RN, [and][ Carroll] Nancy However, [it][ is][ not] likely [to][ be][ achieved] Holayel, BS, [Thomas] Meeks, BA, [Mazen] Mustafa, Banks, MA, [Steven] Berry, BA, [Monie] Clayton, through [an][ intervention][ such] as that MS, [and][ Juan] Vegarra, [BS] (programmers). Patricia Hartwell, MAT, Nan Hubbard, Isabel implemented by [SUPPORT.][ Success][ will] National Statistical Center, Duke University Kussin, BA, [Barbara] Norman, BA, [Jackie] Noveau, require [reexamination][ of][ our][ individual] andMedical Frank Center, E. Harrell, Durham, Jr, PhD. NC: Carlos Alzóla, MS, BSN,MSW (interviewers);[Heather] Read, Jane BA, Castle,[and][ Barbara] MSN, RN,Warren, Beth
and collective commitment to these goals, Beth Israel Hospital, Boston, Mass: Lee Gold¬ Fraulo, BSN, RN, [Rene] Oliverio, BSN, RN, [and]
more creative efforts at shaping the treat¬ man, MD, MPH (principal investigator); E. Francis Kathy Turner, MSN, [RN] (SUPPORT [nurse][ clini¬]
ment process, and, perhaps, more pro¬ Cook, ScD, Mary [Beth] Hamel, MD, Lynn Peterson, cians); [and][ Rosalie][ Perdue] (data manager).
active and forceful attempts at change. MD,Lachlan[Russell] Forrow,[ S.] MD,Phillips, Linda MD, Lesky,[Joel] MD,Tsevat, and Roger MD, AlfredMetroHealth F. Connors, Medical Jr, MD, Center, and Neal Cleveland, V. Dawson, Ohio:

The SUPPORT principal investigators: Alfred Davis, [ScD] (coinvestigators); Nancy Kressin, MS, MD (co-principal investigators); Claudia Coulton,
F. Connors, Jr, MD, and Neal V. Dawson, MD, and Jeanmarie Solzan, BA (interview supervisors); PhD, [C.][ Seth] Landefeld, MD, [Theodore] Speroff,
MetroHealth Medical Center, Cleveland, Ohio; Ann Louise Puopolo, BSN, RN (chart abstractor PhD, [and][ Stuart] Youngner, [MD] (coinvestigators);
Norman A. Desbiens, MD, Marshfield (Wis) Medi¬ supervisor); [Laura] Quimby Barrett, BSN, RN, [Nora] Mary [J.] Kennard, MSN, [and] Mary Naccaratto,
cal Research Foundation; William J. Fulkerson, Jr, Bucko, BSN, RN, [Deborah] Brown, MSN, RN, MSN (chart abstractor supervisors); Mary Jo
MD, [Duke] University [Medical] Center, Durham, Maureen Burns, BSN, RN, Cathy Foskett, BSN, Roach, [PhD] (interviewer supervisor); [Maria][ Blink-]
NC; [Lee] Goldman, MD, MPH, [Beth][ Israel] Hospi¬ RN, Amy Hozid, BSN, RN, [Carol] Keohane, BSN, horn, RN, Cathy Corrigan, RNC, [Elsie] Geric, RN,
tal, Boston, Mass; [William][ A.] Knaus, MD, George RN, [Colleen] Martinez, BSN, RN, [Dorcie][ McWee-] Laura Haas, RN, Jennifer Ham, RN, Julie Jer-
Washington University [Medical] Center, Washing¬ ney, BSN, RN, Debra Melia, BSN, RN, Shelley donek, RN, Marilyn Landy, RN, [Elaine] Marino,
ton, DC; Joanne Lynn, MD, Dartmouth Medical Otto, MSN, RN, Kathy Sheehan, BSN, RN, [Alice] RN, [Patti] Olesen, RN, Sherry Patzke, RN, [Linda]
School, Hanover, NH; [and][ Robert][ K.] Oye, MD, Smith, BSN, RN, [and][ Lauren] Tofias, MS, [RN] (chart Repas, RN, Kathy Schneeberger, RN, Carolyn


-----

Judy Leuenberger, [Linda] Palotta, BA, [and][ Millie] MSW (project director and interviewer supervi¬ Hospital, Boston; Rosalyn Watts, EdD, RN, [Uni¬]
Warren (interviewers); Jane Finley, RN, Toni sor); Darice Moranville-Hawkins, RN, MN, versity [of] Pennsylvania, Philadelphia; Sankey
Ross, RN, [Gillian] Solem, MSN, [and][ Sue] Zronek, Patricia Sheehan, RN, Diane Watanabe, MS, and Williams, MD, Hospital [of][ the] University [of][ Penn¬]
RN (SUPPORT nurse facilitators); and Sara Davis, Myrtle [C.] Yamamoto, [RN] (chart [abstractor] super¬ sylvania; [and][ David] Ransohoff, MD, University [of]
BS (data manager). visors); [Allison] Adema, RN, [Ellen] Adkins, RN, North Carolina at Chapel Hill.

Marshfield Medical Research Foundation/St Ann Marie Beckson, RN, Mona Carter, RN, Ellen
Joseph's Hospital, Marshfield, [Wis:][ Norman][ A.] Duerr, RN, Ayam El-Hadad, RN, MN, [Ann][ Fär¬] The SUPPORT Project was sponsored by the
Desbiens, MD (principal investigator); Steven ber, RN, MA, [Ann] Jackson, RN, [John] Justice, RN, Robert Wood Johnson Foundation.
Broste, MS, [and][ Peter] Layde, MD, [MSc] (co-principal and Agnes O'Meara, RN (chart abstractors); Lee We are grateful for the contribution of the
investigators); [Michael] Kryda, MD, Douglas [J.][ Red¬] Benson, Lynette Cheney, [Carlo] Medina, [and][ Jane] SUPPORT nurse clinicians and chart and inter¬
ing, MD, [and][ Humberto][ J.] Vidaillet, Jr, [MD] (coin- Moriarty (interviewers); Kay Baker, RN, MN, view supervisors and staff whose dedicated efforts
vestigators); Marilyn Folien, RN, [MSN] (project Cleine Marsden, RN, MN, and Kara Watne, RN, ensured the high quality of the data. We also are
manager [and][ chart][ abstractor] supervisor); Patsy MPH (clinical nurse liaisons); and Diane Goya, MA grateful [for][ the][ contributions][ of][ the] patients, [sur¬]
Mowery, [BBA] (interviewer supervisor); [Barbara][ E.] (data manager). rogates, [and] physicians [who] participated [in][ the]
Backus, [Debra][ L.] Kempf, BSN, [Jill][ M.] Kupfer, [Karen] Steering [Committee:][ Alfred][ F.] Connors, Jr, [MD] interviews and intervention.
E. Maassen, LPN, Jean M. Rohde, LPN, Nancy L. (chair), [Norman] Desbiens, MD, [William][ J.][ Fulker¬] All methods of the SUPPORT project are avail¬
Wilke, and Sharon M. Wilke, LPN (chart abstrac¬ son, MD, Frank E. Harrell, Jr, PhD, William A. able to investigators for further study and imple¬
tors); [Elizabeth][ A.] Albee, BA, [Barbara] Backus, [An¬] Knaus, MD, [Joanne] Lynn, MD, [Robert][ K.] Oye, MD, mentation. Details of the day 3 survival and
gela [M.] Franz, BS, [Diana][ L.] Henseler, [Juanita][ A.] and Russell S. Phillips, MD. functional status models have been published,2^6
Herr, [Irene] Leick, [Carol][ L.] Lezotte, BS, [and][ Laura] National Advisory Committee: Charles C. J. and models for other days are available from the
Meddaugh (interviewers); [Linda] Duffy, RN, MSN, Carpenter, [MD] (chair), [Brown] University/The authors, [as][ is][ technical][ information][ on][ baseline][ risk]
Debrah Johnson, RN, BSN, Susan Kronenwetter, Miriam Hospital, Providence, RI; Ronald A. Car¬ or propensity scores for SUPPORT'S major tar¬
RN, BSN, [and][ Anne] Merkel, RN, [BSN] (SUPPORT son, PhD, University of Texas, Galveston; Don E. gets. Requests [for][ these][ materials][ should][ be][ sent]
nurse facilitators). Detmer, MD, University [of] Virginia, [Charlottes-] to William A. Knaus, MD, ICU Research Unit, Box

University [of][ California][ at][ Los] Angeles [Medi¬] ville; [Donald][ E.] Steinwachs, PhD, [The][ Johns] Hop¬ 600, University [of] Virginia [Health][ Sciences] Center,
cal Center: Robert K. Oye, MD (principal investí- kins University, Baltimore, Md; Vincent Mor, PhD, Charlottesville, [VA][ 22908.]

References

1. Callahan D. The Troubled Dream ofLife: Living 18. Bedell SE, Delbanco TL. Choices about car- significance [based][ on][ stratification] by [a][ multivar-]
With Mortality. New York, NY: Simon & Schuster; diopulmonary [resuscitation][ in][ the] hospital. [N] Engl iate confounder score or by a propensity score.
1993. J Med. 1984;310:1089-1093. J Clin Epidemiol. 1989;42:317-324.
2. McCue JD. The naturalness of dying. JAMA. 19. Katz J. The Silent World of Doctor & Patient. 35. Hochberg Y, Benjamini Y. More powerful pro-
1995;273:1039-1043. New York, NY: Free Press; 1986. cedures for multiple significance testing. Stat Med.
3. Annas GJ. Death by prescription: the Oregon 20. Blackhall LJ, Cobb J, Moskowitz MA. Discus- 1990:811-818.
initiative. N Engl J Med. 1994;301:1240-1243. sions regarding aggressive care with critically ill 36. Statistical Sciences. S-Plus Users Manual, Ver-
4. Brown D. Medical community still divided on patients. [J][ Gen][ Intern][ Med.] 1989;4:399-402. sion 3.2. Seattle, Wash: StatSci, MathSoft Inc; 1993.
Oregon's [assisted][ suicide][ law.] Washington [Post.] 21. Arkes HR, Dawson NV, Speroff T, et al. The 37. Harrell FE. Design: S-Plus functions for biosta-
November 13, 1994:A20. covariance decomposition of the probability score tistical/epidemiologic modeling, testing, estimation,
5. Tomlinson T, Brody H. Futility and the ethics of and its use in evaluating prognostic estimates. Med validation, graphics, prediction, [and] typesetting. [1994.]
resuscitation. JAMA. 1990;264:1276-1280. Decis Making. 1995;15:120-131. Available on the Internet at lib.stat.cmu.edu.
6. Blackhall LJ. Must we always [use] CPR? N Engl 22. Molloy DW, Guyatt G, Alemayehu E, McIloy 38. Layde PM, Broste SK, Desbiens N, [et] al. Gen-
J Med. 1987;317:1281-1285. W. Treatment preferences, attitudes toward ad- eralizability [of] [clinical][ studies][ conducted][ at] tertiary
7. Wanzer SH, Federman DD, Adelstein SJ, et al. vance directives, and concerns about health care. care medical centers. J Clin Epidemiol. In press.
The physician's responsibility toward hopelessly ill Humane Med. 1991;7:285-290. 39. Covinsky KE, Goldman L, Cook EF, et al. The
patients. [N] Engl [J][ Med.] 1989;320:884-849. 23. Teno JM, Lynn J, Phillips RS, [et] al. Do formal impact [of] [serious][ illness][ on] patients' [families.][ JAMA.]
8. Ginzberg E. The high [cost] of dying. Inquiry. advance directives affect resuscitation decisions and 1994;272:1839-1844.
1980;17:293-295. the use of resources for seriously ill patients? J Clin 40. Wachter RM, Luce JM, Hearst N, Lo B. De-
9. Hill TP, Shirley D. A Good Death. Reading, Mass: Ethics. 1994;5:23-30. cisions about resuscitation: inequities among pa-
Addison-Wesley; [1992.] 24. Teno JM, Hakim RB, Knaus WA, et al. Pref- tients with different but similar prognosis. Ann
10. President's Commission for the Study of Ethi- erences for CPR: physician-patient agreement and Intern Med. 1989;111:525-532.
cal Problems in Medicine and Biomedical and Be- hospital [resource][ use.][ J][ Gen][ Intern][ Med.] 1995;10: 41. Davidson KW, Hackler C, Caradine DR,
havioral Research. Deciding [to] Forego Life-Sus- 179-186. McCord RS. Physicians' attitudes on advance di-
taining [Treatment.] Washington, [DC:][ US][ Govern-] 25. Wu AW, Damiano AM, Lynn J, et al. Predicting rectives. JAMA. 1989;262:2415-2419.
ment Printing Office; 1983. future functional status for seriously ill hospitalized 42. Brody DS, Miller SM, Lerman CE, [et] al. Pa-
11. Hastings Center. Guidelines on the Termina- adults. Ann Intern Med. 1995;122:342-350. tient perception of involvement in medical care.
tion of Life-Sustaining Treatment and the Care of 26. Knaus WA, Harrell FE, Lynn J, [et] al. The J Gen Intern Med. 1989;4:506-511.
the Dying. New York, NY: Hastings Center; 1987. SUPPORT prognostic model: objective estimates 43. Uhlmann RF, Pearlman RA, Cain KC. Physi-
12. Coordinating Council on Life-Sustaining Medi- of survival for seriously ill hospitalized adults. Ann cians' and spouses' predictions of elderly patients'
cal Treatment Decisions by the Court. Guidelines Intern Med. 1995;122:191-203. resuscitation preferences. J Gerontol. 1988;43:M115\x=req-\
for [State][ Court][ Decision] Making [in] Authorizing [or] 27. LynnJ, Knaus WA. Background for SUPPORT. M121.

Withholding Life-Sustaining [Medical][ Treatment.] J Clin Epidemiol. 1990;43(suppl):1S-4S. 44. Cook DJ, Guyatt GH, Jaeschke R, [et] al. De-
Williamsburg, [Va:][ West] Publishing Company; [1991.] 28. Murphy DJ, Knaus WA, Lynn J. Study popu- terminants in Canadian health care workers of the
13. Cruzan V, director, Missouri Dept of Health. lation in SUPPORT. J Clin Epidemiol. 1990;43 decision [to] withdraw life support from the critically
110 SCt 284, 1990:2855-2856. (suppl):11S-28S. ill. JAMA. 1995;273:703-708.
14. Council on Ethical and Judicial Affairs. Guide- 29. Knaus WA, Wagner DP, Draper EA, et al. The 45. Danis M, Patrick DL, Southerland LI, [et] al.
lines for the appropriate use of do-not-resuscitate APACHE III prognostic system. Chest. 1991;100: Patients' and families' preferences for medical in-
orders. JAMA. 1991;265:1868-1871. 1619-1636. tensive care. JAMA. 1988;260:797-802.
15. American Thoracic Society Bioethics Task 30. Knaus WA, Draper EA, Wagner DP, Zimmer- 46. Tversky A, Shafir E. Choice under conflict: the
Force. Withholding and withdrawing life-sustain- man JE. APACHE II: a severity of disease clas- dynamics [of][ deferred][ decision.] Psychol [Sci.] 1992;
ing therapy. [Ann][ Intern][ Med.] 1991;115:478-485. sification system. Crit Care Med. 1985;13:818-829. 3:358-361.
16. Cancer Pain Relief and Palliative Care. Report 31. Cullen DJ, CivettaJM, Briggs BA, Ferrara LC. 47. Redelmeir DA, Shafir E. Medical decision mak-
of [a][ WHO] Expert Committee, [Technical] Report Therapeutic [Intervention] Scoring System. [Crit][ Care] ing [in][ situations][ that][ offer] multiple [alternatives.]
804. Geneva, Switzerland: World Health Organiza- Med. 1974;2:57-60. JAMA. 1995;273:302-305.
tion; [1990.] 32. Ware JE Jr, Synder MK, Wright WR, Davies 48. Greco PJ, Eisenberg JM. Changing physician's
17. Omnibus Budget Reconciliation Act of 1990 AR. Defining and measuring patient satisfaction with practices. [N] Engl [J][ Med.] 1993;329:1271-1274.
(OBRA-90), [Pub][ L] 101-508, [\s=s\\s=s\4206][and][ 4751] (Medi- medical care. Eval Program Plann. 1983;6:247-263. 49. Neuland S. How We Die: Reflections on Life's
care and Medicaid, respectively), 42 USC \s=s\\s=s\1395cc 33. Cox DR. Regression models and life tables. Final Chapter. New York, NY: Alfred A Knopf
(a)(I)(Q), [1395mm] (c)(8), 1395cc(f), 1396a(a)(57), J Royal Stat Society B. 1972;34:187-220. Inc; [1994.]
1396a(a)(58), [and] 1396a(w) (supp 1991). 34. Cook EF, Goldman L. Performance of tests of


-----

